229 related articles for article (PubMed ID: 30910395)
1. Inferring biallelism of two FSH receptor mutations associated with spontaneous ovarian hyperstimulation syndrome by evaluating FSH, LH and HCG cross-activity.
Lazzaretti C; Riccetti L; Sperduti S; Anzivino C; Brigante G; De Pascali F; Potì F; Rovei V; Restagno G; Mari C; Lussiana C; Benedetto C; Revelli A; Casarini L
Reprod Biomed Online; 2019 May; 38(5):816-824. PubMed ID: 30910395
[TBL] [Abstract][Full Text] [Related]
2. Presence and absence of follicle-stimulating hormone receptor mutations provide some insights into spontaneous ovarian hyperstimulation syndrome physiopathology.
De Leener A; Montanelli L; Van Durme J; Chae H; Smits G; Vassart G; Costagliola S
J Clin Endocrinol Metab; 2006 Feb; 91(2):555-62. PubMed ID: 16278261
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of a mutated FSH receptor detected in a patient with spontaneous ovarian hyperstimulation syndrome.
Uchida S; Uchida H; Maruyama T; Kajitani T; Oda H; Miyazaki K; Kagami M; Yoshimura Y
PLoS One; 2013; 8(9):e75478. PubMed ID: 24058690
[TBL] [Abstract][Full Text] [Related]
4. Identification of the first germline mutation in the extracellular domain of the follitropin receptor responsible for spontaneous ovarian hyperstimulation syndrome.
De Leener A; Caltabiano G; Erkan S; Idil M; Vassart G; Pardo L; Costagliola S
Hum Mutat; 2008 Jan; 29(1):91-8. PubMed ID: 17721928
[TBL] [Abstract][Full Text] [Related]
5. Does elevated human chorionic gonadotropin alone trigger spontaneous ovarian hyperstimulation syndrome?
Michaelson-Cohen R; Altarescu G; Beller U; Reens R; Halevy-Shalem T; Eldar-Geva T
Fertil Steril; 2008 Nov; 90(5):1869-74. PubMed ID: 18166181
[TBL] [Abstract][Full Text] [Related]
6. A mutation in the follicle-stimulating hormone receptor as a cause of familial spontaneous ovarian hyperstimulation syndrome.
Montanelli L; Delbaere A; Di Carlo C; Nappi C; Smits G; Vassart G; Costagliola S
J Clin Endocrinol Metab; 2004 Apr; 89(4):1255-8. PubMed ID: 15080154
[TBL] [Abstract][Full Text] [Related]
7. A mutation in the follicle-stimulating hormone receptor as a cause of familial spontaneous ovarian hyperstimulation syndrome.
Montanelli L; Delbaere A; Di Carlo C; Nappi C; Smits G; Vassart G; Costagliola S
J Clin Endocrinol Metab; 2004 Mar; 89(3):1255-8. PubMed ID: 15001619
[TBL] [Abstract][Full Text] [Related]
8. Two different entities of spontaneous ovarian hyperstimulation in a woman with FSH receptor mutation.
Dieterich M; Bolz M; Reimer T; Costagliola S; Gerber B
Reprod Biomed Online; 2010 Jun; 20(6):751-8. PubMed ID: 20378412
[TBL] [Abstract][Full Text] [Related]
9. Specificity of cognate ligand-receptor interactions: fusion proteins of human chorionic gonadotropin and the heptahelical receptors for human luteinizing hormone, thyroid-stimulating hormone, and follicle-stimulating hormone.
Schubert RL; Narayan P; Puett D
Endocrinology; 2003 Jan; 144(1):129-37. PubMed ID: 12488338
[TBL] [Abstract][Full Text] [Related]
10. Functional characterization of two naturally occurring mutations V
Banerjee AA; Achrekar SK; Joseph S; Pathak BR; Mahale SD
Mol Cell Endocrinol; 2017 Jan; 440():69-79. PubMed ID: 27889471
[TBL] [Abstract][Full Text] [Related]
11. Ovarian hyper-stimulation syndrome after spontaneous conception.
Lussiana C; Guani B; Restagno G; Rovei V; Menato G; Revelli A; Massobrio M
Gynecol Endocrinol; 2009 Jul; 25(7):455-9. PubMed ID: 19499413
[TBL] [Abstract][Full Text] [Related]
12. First mutation in the FSHR cytoplasmic tail identified in a non-pregnant woman with spontaneous ovarian hyperstimulation syndrome.
Hugon-Rodin J; Sonigo C; Gompel A; Dodé C; Grynberg M; Binart N; Beau I
BMC Med Genet; 2017 Apr; 18(1):44. PubMed ID: 28446136
[TBL] [Abstract][Full Text] [Related]
13. Effects of a thyroid-stimulating human monoclonal autoantibody (M22) on functional activity of LH and FSH receptors.
Tonacchera M; Ferrarini E; Dimida A; Agretti P; De Marco G; Pinchera A; Sanders J; Evans M; Richards T; Furmaniak J; Smith BR
Thyroid; 2006 Nov; 16(11):1085-9. PubMed ID: 17123334
[TBL] [Abstract][Full Text] [Related]
14. Ovarian hyperstimulation syndrome (OHSS) due to mutations in the follicle-stimulating hormone receptor.
Rodien P; Beau I; Vasseur C
Ann Endocrinol (Paris); 2010 May; 71(3):206-9. PubMed ID: 20362966
[TBL] [Abstract][Full Text] [Related]
15. Symposium: Update on prediction and management of OHSS. Genetics of ovarian hyperstimulation syndrome.
Rizk B
Reprod Biomed Online; 2009 Jul; 19(1):14-27. PubMed ID: 19573286
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous ovarian hyperstimulation syndrome.
Kasum M; Oresković S; Jezek D
Coll Antropol; 2013 Jun; 37(2):653-6. PubMed ID: 23941020
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the roles of follicle-stimulating hormone receptor polymorphisms in gonadal hyperstimulation associated with severe juvenile primary hypothyroidism.
Ryan GL; Feng X; d'Alva CB; Zhang M; Van Voorhis BJ; Pinto EM; Kubias AE; Antonini SR; Latronico AC; Segaloff DL
J Clin Endocrinol Metab; 2007 Jun; 92(6):2312-7. PubMed ID: 17356048
[TBL] [Abstract][Full Text] [Related]
18. Ovarian hyperstimulation syndrome in a spontaneous pregnancy with invasive mole.
Wu X; Zhu J; Zhao A
J Obstet Gynaecol Res; 2015 May; 41(5):817-22. PubMed ID: 25492410
[TBL] [Abstract][Full Text] [Related]
19. The C-terminal third of the human luteinizing hormone (LH) receptor is important for inositol phosphate release: analysis using chimeric human LH/follicle-stimulating hormone receptors.
Hirsch B; Kudo M; Naro F; Conti M; Hsueh AJ
Mol Endocrinol; 1996 Sep; 10(9):1127-37. PubMed ID: 8885247
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathology of the FSH receptor: new insights into FSH physiology.
Meduri G; Bachelot A; Cocca MP; Vasseur C; Rodien P; Kuttenn F; Touraine P; Misrahi M
Mol Cell Endocrinol; 2008 Jan; 282(1-2):130-42. PubMed ID: 18248882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
